Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond

Metadata

Authors/Creators:	Chim, CS Kumar, SK Orlowski, RZ Cook, G https://orcid.org/0000-0003-0223-3652 Richardson, PG Gertz, MA Giralt, S Mateos, MV Leleu, X Anderson, KC
Commentary on:	Chim, CS, Kumar, SK, Orlowski, RZ et al. (7 more authors) (2018) Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond. Leukemia, 32 (2). pp. 252-262. ISSN 0887-6924
Copyright, Publisher and Additional Information:	© The Author(s) 2019. This is an open access article under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) (https://creativecommons.org/licenses/by/4.0/)
Dates:	Accepted: 16 November 2017 Published (online): 6 March 2019 Published: April 2019
Institution:	The University of Leeds
Depositing User:	Symplectic Publications
Date Deposited:	12 Feb 2020 10:45
Last Modified:	12 Feb 2020 10:45
Status:	Published
Publisher:	Springer Nature
Identification Number:	https://doi.org/10.1038/s41375-019-0410-3

Chim, CS, Kumar, SK, Orlowski, RZ, Cook, G, Richardson, PG, Gertz, MA, Giralt, S, Mateos, MV, Leleu, X and Anderson, KC Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond. (deposited 12 Feb 2020 10:42)
- Chim, CS, Kumar, SK, Orlowski, RZ, Cook, G, Richardson, PG, Gertz, MA, Giralt, S, Mateos, MV, Leleu, X and Anderson, KC Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond. (deposited 12 Feb 2020 10:45) [Currently Displayed]

Filename: s41375-019-0410-3.pdf

Licence: CC-BY 4.0

CLICK TO DOWNLOAD

CORE (COnnecting REpositories)